BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 28/08/1997

Regulatory Workshop to Discuss Potency and Dosage of von Willebrand Factor Concentrates

The FDA is hosting a public workshop to discuss the potency and dosage of von Willebrand factor concentrates, which are used to treat bleeding disorders such as hemophilia A and von Willebrand disease.

Source: Federal Register — Food and Drug AdministrationOpen original release →